Brown Advisory
BIO icon

Brown Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$224K Sell
927
-157
-14% -$37.9K ﹤0.01% 1268
2025
Q1
$264K Sell
1,084
-344
-24% -$83.8K ﹤0.01% 1177
2024
Q4
$469K Sell
1,428
-870
-38% -$286K ﹤0.01% 1035
2024
Q3
$769K Sell
2,298
-1,222
-35% -$409K ﹤0.01% 854
2024
Q2
$961K Sell
3,520
-12,922
-79% -$3.53M ﹤0.01% 780
2024
Q1
$5.69M Buy
16,442
+873
+6% +$302K 0.01% 477
2023
Q4
$5.03M Sell
15,569
-940,163
-98% -$304M 0.01% 484
2023
Q3
$343M Buy
955,732
+28,724
+3% +$10.3M 0.56% 46
2023
Q2
$351M Buy
927,008
+80,607
+10% +$30.6M 0.55% 48
2023
Q1
$405M Buy
846,401
+25,516
+3% +$12.2M 0.69% 38
2022
Q4
$345M Buy
820,885
+45,173
+6% +$19M 0.64% 41
2022
Q3
$324M Buy
775,712
+193,896
+33% +$80.9M 0.63% 42
2022
Q2
$288M Buy
581,816
+80
+0% +$39.6K 0.54% 48
2022
Q1
$328M Buy
581,736
+42,375
+8% +$23.9M 0.49% 50
2021
Q4
$408M Sell
539,361
-31,847
-6% -$24.1M 0.51% 54
2021
Q3
$426M Buy
571,208
+1,976
+0.3% +$1.47M 0.63% 47
2021
Q2
$367M Buy
569,232
+37,045
+7% +$23.9M 0.55% 54
2021
Q1
$304M Buy
532,187
+56,515
+12% +$32.3M 0.52% 55
2020
Q4
$277M Buy
475,672
+10,263
+2% +$5.98M 0.49% 56
2020
Q3
$240M Buy
465,409
+50,277
+12% +$25.9M 0.5% 55
2020
Q2
$187M Buy
415,132
+70,846
+21% +$32M 0.44% 57
2020
Q1
$121M Buy
344,286
+115,774
+51% +$40.6M 0.37% 59
2019
Q4
$84.6M Buy
+228,512
New +$84.6M 0.21% 96
2019
Q2
Sell
-1,226
Closed -$376K 1053
2019
Q1
$376K Buy
1,226
+159
+15% +$48.8K ﹤0.01% 1067
2018
Q4
$248K Buy
1,067
+139
+15% +$32.3K ﹤0.01% 1120
2018
Q3
$291K Buy
928
+18
+2% +$5.64K ﹤0.01% 1151
2018
Q2
$262K Sell
910
-40
-4% -$11.5K ﹤0.01% 1149
2018
Q1
$238K Buy
+950
New +$238K ﹤0.01% 1058